MIME-Version: 1.0
Date: Mon, 18 May 2020 18:08:36 -0400
References: <CACNgykPf85sxHJX+NXztwqed0aqzYoe9vYFSYtG_DNH0piEfqg@mail.gmail.com>
In-Reply-To: <CACNgykPf85sxHJX+NXztwqed0aqzYoe9vYFSYtG_DNH0piEfqg@mail.gmail.com>
Message-ID: <CACNgykNHMqXsHUUgGBK=1QkiSmA-hm3UTwzfSZ1zWeT_tgoCmA@mail.gmail.com>
Subject: Re: On rec. of Simon Milner at Miller Insurance
From: Josh Klein <josh@josh.is>
To: cristina.varner@theabdteam.com
Cc: Joshua William Klein <josh@josh.is>
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Just following up - let me know if I can provide any further info.

best,
Josh

On Fri, May 8, 2020 at 11:16 AM Josh Klein <josh@josh.is> wrote:
>
> You were suggested as a good person to contact reg. clinical trials for C=
ontinuous Glucose Monitors; I've been in discussion with Abbot and am curio=
us to talk to someone in the US who can help me understand what an insurer =
might look for. Do you have time for a brief call in the next couple weeks?
>
> All best wishes,
> Josh
> =E1=90=A7
